Literature DB >> 7053427

Myocardial disposition and cardiac pharmacodynamics of verapamil in the dog.

D L Keefe, R E Kates.   

Abstract

The disposition of verapamil was studied in anesthetized open-chested dogs following administration of intravenous doses of 0.5 mg/kg. The plasma and myocardial verapamil concentration-time data were fit to a three-compartment model to describe the disposition kinetics. The distribution equilibrium between myocardium and plasma was achieved rapidly and the concentration of verapamil decayed in parallel in these two tissues. The partition coefficient which describes the time averaged myocardial/plasma concentration ratio was 6.21 +/- 2.38. Examination of the relationship between the plasma and myocardial concentrations and the time course of the effect of verapamil, as defined as PR interval prolongation, revealed a hysteresis effect in some dogs. Despite this hysteresis, there was a linear relationship between plasma and myocardial concentrations of verapamil and the degree of prolongation of the PR interval. The results of this study indicate that the concentration in the plasma is in equilibrium with the myocardium and changes in plasma concentration are indicative of parallel changes in myocardial levels. The effect of verapamil on the atrioventricular node is related to the concentration in the myocardium and plasma, but there is substantial interanimal variability in the sensitivity to verapamil.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053427

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Myocardial uptake of drugs and clinical effects.

Authors:  J D Horowitz; A C Powell
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

2.  Neuromuscular blocking action of verapamil in cats.

Authors:  B J Kraynack; N W Lawson; J Gintautas
Journal:  Can Anaesth Soc J       Date:  1983-05

3.  Modeling cardiac uptake and negative inotropic response of verapamil in rat heart: effect of amiodarone.

Authors:  Pakawadee Sermsappasuk; Osama Abdelrahman; Michael Weiss
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

4.  Myocardial uptake of lignocaine: pharmacokinetics and pharmacodynamics in the isolated perfused heart of the rabbit.

Authors:  J X Mazoit; J P Kantelip; E E Orhant; J M Talmant
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

5.  Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man.

Authors:  R Padrini; E Barbieri; D Piovan; M Toffoli; A Motta; G P Trevi; M Ferrari
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Evaluation of the protective effect of verapamil on reperfusion injury by 111In anticardiac myosin antibody in canine myocardial infarction.

Authors:  J K Chung; S M Lim; M C Lee; C S Koh; M Lee; J W Seo
Journal:  Ann Nucl Med       Date:  1991-09       Impact factor: 2.668

7.  Binding of diltiazem and verapamil to isolated rat heart mitochondria.

Authors:  J Rafael; J Patzelt
Journal:  Basic Res Cardiol       Date:  1987 May-Jun       Impact factor: 17.165

Review 8.  Clinical pharmacokinetics of verapamil.

Authors:  S R Hamann; R A Blouin; R G McAllister
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

9.  Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium.

Authors:  A D Sharma; J E Saffitz; B I Lee; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.